8月6日，麦克森药物批发盘中上涨4.02%，报885.62美元/股，成交额1.35亿美元。消息面上，公司盘后发布2027财年第一季度财报，业绩全面超出市场预期。调整后每股收益为9.93美元，超出市场一致预期的9.54美元约4.1%，同比增长20.2%；营收1053.8亿美元，超出预期的1037.4亿美元。此前上季度营收曾显著不及预期引发市场担忧，本季度收入端强劲修复有效提振信心。
此外，公司将全年调整后EPS指引上调至44.20至45.00美元区间，高于此前43.80至44.60美元的指引及市场预期的44.26美元。美银证券同步将目标价由950美元大幅上调至1050美元，进一步强化看多情绪。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.